Affective bipolar disorder and ambivalence in relation to the drug treatment: Analyzing the causal conditions

Revista da Escola de Enfermagem

Volumn 45, Issue 2, 2011, Pages 425-432

  Miasso, Adriana Inocenti ^a   Cassiani, Silvia Helena De Bortoli ^a   Pedrão, Luiz Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Drug administration schedule; Family; Therapeutics

Indexed keywords

ARTICLE; BIPOLAR DISORDER; DRUG ADMINISTRATION; HUMAN;

BIPOLAR DISORDER; DRUG ADMINISTRATION SCHEDULE; HUMANS;

EID: 79958791302     PISSN: 00806234     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0080-62342011000200019     Document Type: Article

References (20)

1. Kasper S. Issues in the treatment of bipolar disorder. Eur Neuropsychopharmacol. 2003;13 Suppl 2:S37-42.
2. Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J Affect Disord. 2000;59(3):237-41.
3. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164-72.
4. Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv. 2004;55(3):264-9.
5. Cerulli J. The role of the community pharmacist in identifying, preventing and resolving drug-related problems. Medscape Pharm. 2001;2(2):1-5.
6. Jorge MAS. Textos de apoio em saúde mental. Rio de Janeiro: FIOCRUZ; 2003.
7. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331-42.
8. Leite SN, Vasconcellos MPC. Aderência à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Ciênc Saúde Coletiva. 2003; 8(3):775-82.
9. Teixeira PR, Paiva V, Shimma E. Tá difícil de engolir? São Paulo: NEPAIDS; 2000.
10. rd ed. Englewood Cliffs: Prentice-Hall; 1989.
11. Blumer H. Symbolic interactionism: perspective and method. Berkeley: University of California; 1969.
12. Strauss A, Corbin J. Basics of qualitative research: grounded theory, procedures and techniques. Newbury Park: Sage; 1990.
13. a ed. Porto Alegre: Artmed; 2007.
14. Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, et al. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder base on number of previous manic or mixed episodes. J Clin Psychiatry. 2006;67(1):95-101.
15. a ed. Porto Alegre: Medsi; 2002.
16. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesyity related? A review for the mental health professional. J Clin Psychiatry. 2005;65(5):634-51.
17. Sanches RF, Assunção S, Hetem LAB. Impacto da comorbidade no diagnóstico e tratamento do transtorno bipolar. Rev Psiquiatr Clin (São Paulo). 2005;32 Supl 1:71-7.
18. Kerr-Corrêa F, Souza LB, Calil HM. Doenças afetivas e sazonalidade no Brasil. Rev ABP-APAL. 1995;17(1):122-6.
19. Knapp P, Isolan L. Abordagens psicoterápicas no transtorno bipolar. Rev Psiquiatr Clin (São Paulo). 2005;32 Supl 1:98-104.
20. Moreno RA, Moreno DH, Soares MBM, Ratzke R. Anticonvulsivantes e antipsicóticos no tratamento do transtorno bipolar. Rev Bras Psiquiatr. 2004;26 Supl 3:37-43.